Transarterial Chemoembolization for Hepatocellular Carcinoma
Authors:
- Simon C.H. YuSYSimon C.H. Yu
- Thomas W.T. LeungTLThomas W.T. Leung
- 1 January 2006
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 202 (1) , 155-168
Abstract
No abstract availableKeywords
This publication has 141 references indexed in Scilit:
- Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survivalHepatology, 2003
- Chemoembolization of Hepatocellular CarcinomaJournal of Vascular and Interventional Radiology, 2002
- Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trialThe Lancet, 2002
- Prognosis of hepatocellular carcinoma in relation to treatment: A multivariate analysis of 178 patients from a single European institutionSurgery, 1998
- Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trialJournal of Hepatology, 1998
- Spontaneous and iatrogenic spreading of liver-derived cells into peripheral blood of patients with primary liver cancerHepatology, 1997
- Pulmonary metastasis of hepatocellular carcinoma associated with transarterial chemoembolizationJournal of Hepatology, 1995
- Treatment of hepatocellular carcinoma using doxorubicin/ethiodized oil/gelatin powder chemoembolizationCancer, 1993
- Postresection Recurrence of Hepatocellular Carcinoma Treated by Arterial Embolization: Analysis of Prognostic FactorsHepatology, 1992
- A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinomaJournal of Hepatology, 1990